Literature DB >> 9575920

Continuous release of vasodilator prostanoids contributes to regulation of resting forearm blood flow in humans.

S J Duffy1, B T Tran, G New, R N Tudball, M D Esler, R W Harper, I T Meredith.   

Abstract

Continuous release of nitric oxide contributes to the maintenance of resting tone in the human forearm and coronary circulations; however, evidence for a similar role of vasodilator prostanoids such as prostacyclin is lacking. We examined whether continuous release of prostacyclin contributes to basal forearm blood flow. Flow was measured using venous occlusion plethysmography in 38 healthy volunteers [mean age 21.3 +/- 2.5 yr (+/- SD); 13 female, 25 male] at rest, after administration of three incremental intra-arterial infusions of either the cyclooxygenase inhibitor aspirin or placebo, and before and after administration of the endothelium-dependent and -independent dilators acetylcholine (30 micrograms/min) and nitroprusside (1 microgram/min). To assess the effect of aspirin on the production of prostacyclin, plasma 6-keto prostaglandin F1 alpha (6-keto-PGF1 alpha; the stable metabolite of prostacyclin) was measured by simultaneous arterial and venous sampling. Aspirin produced a time- and dose-dependent reduction in forearm blood flow, resulting in a 32% decrease at the highest dose. The effect was maximal after 10 min. Flow at rest and after aspirin doses of 1, 3, and 10 mg/min was 2.6 +/- 0.2, 2.3 +/- 0.2, 2.1 +/- 0.2, and 1.8 +/- 0.2 ml.100 ml forearm tissue-1.min-1, respectively (means +/- SE, P < 0.001). Commensurate with these data, the net forearm production of 6-keto-PGF1 alpha was 52.9 +/- 16.4, 11.7 +/- 8.6, 18.7 +/- 8.5, and 12.0 +/- 12.5 pg.100 ml forearm tissue-1.min-1 for the respective doses (P = 0.04). No time-dependent reduction in flow was seen in subjects with vehicle infusion. Aspirin did not affect the responses to acetylcholine or nitroprusside. These data suggest that continuous release of prostacyclin plays a role in the maintenance of resting forearm blood flow. There appears to be a direct link between the reduction in flow with aspirin and inhibition of prostacyclin production.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9575920     DOI: 10.1152/ajpheart.1998.274.4.H1174

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

1.  Responses to endothelin-1 in patients with advanced cirrhosis before and after liver transplantation.

Authors:  P W Angus; R B Vaughan; J P F Chin-Dusting
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

2.  Vascular responses of the extremities to transdermal application of vasoactive agents in Caucasian and African descent individuals.

Authors:  Matthew J Maley; James R House; Michael J Tipton; Clare M Eglin
Journal:  Eur J Appl Physiol       Date:  2015-04-04       Impact factor: 3.078

3.  Effect of aspirin on vasodilation to bradykinin and substance P in patients with heart failure treated with ACE inhibitor.

Authors:  Andrew P Davie; John J V McMurray
Journal:  Br J Clin Pharmacol       Date:  2002-01       Impact factor: 4.335

4.  Sympathetic and cardiovascular responses to glossopharyngeal insufflation in trained apnea divers.

Authors:  Karsten Heusser; Gordan Dzamonja; Toni Breskovic; Craig D Steinback; André Diedrich; Jens Tank; Jens Jordan; Zeljko Dujic
Journal:  J Appl Physiol (1985)       Date:  2010-09-23

5.  Endothelium-derived hyperpolarizing factor mediates bradykinin-stimulated tissue plasminogen activator release in humans.

Authors:  Ayaz M Rahman; Jonathan R Murrow; Muhiddin A Ozkor; Nino Kavtaradze; Ji Lin; Christine De Staercke; W Craig Hooper; Amita Manatunga; Salim Hayek; Arshed A Quyyumi
Journal:  J Vasc Res       Date:  2014-06-04       Impact factor: 1.934

Review 6.  Anti-inflammatory strategies in hypertension: focus on COX-1 and COX-2.

Authors:  Matthias Hermann; Frank Enseleit; Frank T Ruschitzka
Journal:  Curr Hypertens Rep       Date:  2005-02       Impact factor: 5.369

Review 7.  Endothelium-mediated control of vascular tone: COX-1 and COX-2 products.

Authors:  Michel Félétou; Yu Huang; Paul M Vanhoutte
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

8.  Nitric oxide, prostanoid and non-NO, non-prostanoid involvement in acetylcholine relaxation of isolated human small arteries.

Authors:  N H Buus; U Simonsen; H K Pilegaard; M J Mulvany
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

9.  ATP-induced vasodilation in human skeletal muscle.

Authors:  E E M van Ginneken; P Meijer; N Verkaik; P Smits; G A Rongen
Journal:  Br J Pharmacol       Date:  2004-02-09       Impact factor: 8.739

10.  Cyclo-oxygenase-2 mediated prostaglandin release regulates blood flow in connective tissue during mechanical loading in humans.

Authors:  H Langberg; R Boushel; D Skovgaard; N Risum; M Kjaer
Journal:  J Physiol       Date:  2003-06-17       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.